NeoGenomics (NEO) Tops Q1 EPS by 1c, provides guidance

NeoGenomics (NASDAQ: NEO) reported Q1 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $168 million versus the consensus estimate of $171.35 million.

GUIDANCE:

NeoGenomics sees FY2025 revenue of $735-745 million, versus the consensus of $738.3 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea